查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1750707

多重分析市場規模、佔有率、趨勢分析報告：按產品、類型、技術類型、應用、最終用途、地區和細分市場，預測至 2025-2030 年

Multiplex Assay Market Size, Share & Trends Analysis Report By Product, By Type, By Technology, By Application, By End User, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

多重分析市場的成長與趨勢

根據 Grand View Research, Inc. 的最新報告，全球多重檢測市場規模預計到 2030 年將達到 44.1272 億美元，預計 2025 年至 2030 年的複合年成長率為 17.5%。

感染疾病的日益普及推動了多重檢測在臨床檢測中的應用。例如，根據美國癌症協會2021年的數據，美國報告的癌症病例為190萬例，導致608.57萬人死亡。多重檢測有助於癌症診斷，並減少不必要的侵入性操作。因此，慢性病的增加預計將推動對這些檢測的需求，並推動市場成長。近年來，個人化醫療的日益普及也是推動市場成長的關鍵因素。

個人化醫療是一種精準醫療，旨在根據患者的個人體質和疾病風險來改善治療方法。這些檢測方法對於個人化醫療的全面診斷非常有益。例如，根據2020年發表在MDPI日誌上的一篇論文，多重免疫測量可以整體情況類風濕性關節炎(RA)的疾病及其相關通路，並透過分析多種蛋白質同時獲得RA亞型的生物標記特徵，使患者受益於個人化醫療。在COVID-19疫情期間，多重檢測仍是醫護人員有效控制COVID-19傳播的重要工具。最近，一些私人公司也開發了新型的多重檢測方法。

例如，2020 年 9 月，LabCorp 推出了用於診斷甲型/乙型流感、新冠肺炎和呼吸道融合細胞病毒單面板測試的家庭採集版本。此外，多重檢測相對於單重檢測和傳統檢測的優勢可能會在未來幾年推動該行業的成長。這些自動化測試提供的一些優勢包括微採樣能力、單次測試可測量大量陣列、快速的結果、高操作效率、操作簡單性以及降低的人事費用。因此，該行業在 2021 年見證了增量成長，預計在預測期內將繼續保持相同的趨勢。此外，分子和蛋白質診斷中生物標記檢驗的增加、對高性能和自動化系統日益成長的需求預計將在預測期內創造有利可圖的機會。

多重生物標記分析在感染疾病、神經退化性疾病、自體免疫疾病和癌症領域有廣泛的應用。人們已經發現了許多生物標記，並且可能會開發出新的診斷方法。例如，Cipla 推出了 RT Direct 多重 PCR套件，可快速獲得 COVID-19 的檢測結果。此類市場發展可能會在預測期內提高多重檢測的市場滲透率。多重檢測的技術進步和自動化正在提高提供準確結果的效率和速度。例如，2020 年 7 月，Luminex 向 xMAP 提供了其 INTELLIFLEX 系統，以發現新的應用，例如其在單次血清學測試中檢測多種抗體的獨特能力。

2022年5月，Vela Diagnostics推出了一種高度自動化的多重PCR檢測方法，用於檢測抗生素抗藥性基因和尿道結石病原體。因此，新技術的發展有望在不久的將來推動該產業的成長。然而，設備成本高昂可能會限制中低收入國家的研究人員和製造商使用多重檢測方法。此外，多重檢測的品管標準和法規比定序重檢測更為嚴格，這可能會在預測期內阻礙該行業的成長。

多重分析市場報告重點

  • 按產品分類，耗材領域在 2024 年佔據主導地位，這是由於隨著診斷測試數量的增加而重複購買耗材。
  • 由於人們越來越關注臨床診斷的生物標記研究和蛋白質組學研究，蛋白質多重檢測類型細分市場在 2024 年佔據了行業主導地位。
  • 流式細胞技術技術領域在 2024 年佔據了主要佔有率。各公司不斷努力推出新穎且技術先進的流式細胞儀是推動這一領域發展的關鍵因素。
  • 2024 年，研發應用領域佔據了最大佔有率，這歸功於在臨床和臨床前階段使用這些檢測來評估毒性、免疫療法成功率和藥物反應生物標記。
  • 2024 年，製藥和生物技術終端用戶部門引領了整個產業，這得益於與製藥和生物技術公司的合作與夥伴關係不斷加強，以提高連接複用能力。
  • 由於慢性病的流行導致研發活動活性化，北美在 2024 年佔據了全球產業的主導地位。
  • 由於新興經濟體的醫院數量不斷增加、研發產業蓬勃發展以及該地區對醫療保健基礎設施的需求旺盛，預計亞太地區將在 2024 年至 2030 年期間實現最快的複合年成長率。

目錄

第1章調查方法

第2章執行摘要

3. 全球多重分析市場變數、趨勢與範圍

  • 多重檢測市場的系統展望
    • 母市場展望
  • 滲透和成長前景圖
  • 市場促進因素分析
    • 慢性病和感染疾病的流行
    • 多重檢測相較於單重檢測和傳統檢測的主要優勢
    • 擴大多重檢測在伴隨診斷的應用
    • 提高早期診斷意識
  • 市場限制因素分析
    • 多重檢測的投資成本高
    • 嚴格的監管約束和標準
  • 市場機會分析
    • 高吞吐量和自動化系統的需求日益增加
    • 增強蛋白質和分子診斷中的生物標記檢驗
  • 波特五力分析
  • SWOT分析（按因素）（政治/法律、經濟、技術）

4. 多重分析市場：細分分析（按產品），2018 年至 2030 年

  • 全球多重分析市場：產品變異分析
  • 耗材
    • 2018-2030年消耗品市場估計與預測
  • 裝置
    • 2018-2030年設備市場估計與預測
  • 軟體
    • 2018-2030 年軟體市場估計與預測

5. 多重分析市場：細分分析（按類型），2018-2030 年

  • 全球多重分析市場：類型變異分析
  • 蛋白質多重檢測
    • 2018-2030年蛋白質多重分析市場估計與預測
  • 核酸多重檢測
    • 2018-2030年核酸多重檢測市場規模預測
  • 基於細胞的多重分析
    • 2018-2030年細胞多重分析市場規模預測

6. 多重分析市場：技術細分分析，2018-2030

  • 多重檢測市場：技術變革分析
  • 流式細胞技術
    • 流式細胞技術市場估計與預測（2018-2030）
  • 螢光偵測
    • 螢光檢測市場規模估計及預測（2018-2030）
  • 照明
    • 2018-2030年發光市場估計與預測
  • 多重即時PCR
    • 2018-2030年多重即時PCR市場預測及預測
  • 其他
    • 2018-2030年其他技術市場估計與預測

7. 多重分析市場：細分分析、按應用，2018-2030 年

  • 多重檢測市場：應用趨勢分析
  • 研究與開發
  • 臨床診斷

8. 多重分析市場：細分分析、依最終用途，2018-2030 年

  • 多重分析市場：最終用途變異分析
  • 製藥和生物技術公司
  • 醫院和診斷實驗室
  • 研究和學術機構
  • 其他

9. 多重分析市場：區域細分分析，2018-2030

  • 多重分析市場：區域差異分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第10章 競爭格局

  • 參與企業概況
  • 公司/競爭對手分類
  • 供應商格局
    • BIO-RAD LABORATORIES, INC.
    • ABCAM PLC.
    • R&D SYSTEMS, INC.
    • MERCK KGAA
    • ASSAY GENIE
    • PROMEGA CONNECTIONS
    • QIAGEN NV
    • THERMO FISHER SCIENTIFIC, INC.
    • LUMINEX CORPORATION
    • PERKIN ELMER INC.
    • ADVANCED CELL DIAGNOSTICS, INC.
    • SEEGENE INC.
Product Code: GVR-4-68039-984-5

Multiplex Assay Market Growth & Trends:

The global multiplex assay market size is estimated to reach USD 4,412.72 million by 2030, registering to grow at a CAGR of 17.5% from 2025 to 2030 according to a new report by Grand View Research, Inc. The growing prevalence of infectious diseases is boosting the usage of multiplex assays in clinical trials. For instance, according to the American Cancer Society in 2021, 1.9 million cancer cases were reported along with 6,08,570 deaths in the United States. Multiplex assay aids in the diagnosis of cancer and reduces unnecessary invasive producers. Thus, growing chronic diseases can boost the necessity of these assays and is anticipated to fuel market growth. The increasing adoption of personalized medicine in recent years is another key factor driving the growth.

Personalized medicine is a precise medicine for an individual patient to attain improved treatment options based on the body type and disease risk. These assays ensure to be highly beneficial for the comprehensive diagnosis of personalized medicines. For instance, according to an article published in the MDPI journal in 2020, multiplex immunoassay provides a complete picture of the disease and pathways involved in Rheumatoid Arthritis (RA) and simultaneously analyzes multiple proteins that can yield biomarker signatures of RA subtypes to enable patients to benefit from personalized medicine. During the COVID-19 pandemic, multiplex testing continued to be an essential tool for healthcare professionals in effectively managing the spread of COVID-19. In addition, recently, several private companies have also developed novel versions of multiplex assays.

For instance, in Sept 2020, LabCorp launched an at-home collection version for diagnosis of influenza A/B, COVID-19, and respiratory syncytial virus single-panel tests. Furthermore, the advantages of multiplex assay over singleplex and traditional assay can boost the industry growth in coming years. Several benefits offered by these automated tests include microsampling capability, numerous arrays measured in a single trial, quicker results, high operational efficiency, easy operations, and reduced labor expenses. Thus, the industry has witnessed incremental growth in 2021 and is anticipated to have a similar trend during the forecast period. Moreover, increasing validation of the biomarkers in molecular & protein diagnostics and the rising need for high-throughput and automated systems are expected to create lucrative opportunities during the forecast period.

Multiple biomarker analysis has a wide range of applications in the area of infectious diseases, neurodegenerative diseases, autoimmune diseases, and cancer. Numerous biomarkers are being discovered, and there is a high possibility of the development of novel diagnostics. For instance, Cipla launched RT Direct multiplex PCR kit that delivers quicker results for COVID-19. Such developments can increase the market penetration of multiplex assay during the forecast period. The technological advancements and automation in the multiplex assay, improve the efficiency and speed of delivering accurate results. For instance, in July 2020, Luminex provided xMAP the INTELLIFLEX system to discover novel applications, including the exclusive ability to detect multiple antibodies in a single serology test.

In May 2022, Vela Diagnostics launched a highly automated multiplex PCR-based test for detecting antimicrobial resistance genes and UTI pathogens. Hence novel technological developments can fuel the industry growth in the near future. However, the high cost of equipment can restrict the usage of multiplex assays by researchers and manufacturers in mid and low-income countries. Also, the quality control standards and regulations are more stringent for multiplex assay compared to singlex assay, which can impede the industry growth during the forecast period.

Multiplex Assay Market Report Highlights:

  • By product, the consumables segment held the dominant share in 2024. This is due to the recurring purchase of consumables along with the rise in the number of diagnostic tests.
  • The protein multiplex assay type segment dominated the industry in 2024 due to the increasing focus on proteomics studies for biomarker research and clinical diagnostics.
  • The flow cytometry technology segment held a larger share in 2024. Constant efforts by various companies to launch novel and technological advanced flow cytometer is the key factor driving the segment.
  • The research & development application segment held the largest share in 2024 due to the utilization of these assays in clinical & preclinical stages to evaluate toxicity, immunotherapy success, and drug response biomarkers.
  • The pharmaceutical & biotechnology companies end-user segment led the industry in 2024 due to a rise in pharma & biotech partnerships and collaborations to increase the multiplexing capabilities.
  • North America dominated the global industry in 2024 due to the growing R&D activities as a result of the increasing prevalence of chronic diseases.
  • Asia Pacific is estimated to register the fastest CAGR from 2024 to 2030 due to the rising number of hospitals in emerging countries, the developing R&D sector, and the high demand for healthcare infrastructure in the region.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity flow approach
      • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 List of Secondary Sources
  • 1.10 List of Primary Sources
  • 1.11 Objectives
  • 1.12 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Summary
  • 2.2 Market Snapshot
  • 2.3 Segment Snapshot
  • 2.3 Competitive Snapshot

Chapter 3 Global Multiplex Assay Market Variables, Trends, & Scope

  • 3.1 Multiplex Assay Market Lineage Outlook
    • 3.1.1 Parent market outlook
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 Market Driver Analysis
    • 3.3.1 Growing prevalence of chronic and infectious diseases
    • 3.3.2 Significant advantages of multiplex over singleplex and traditional assays
    • 3.3.3 Increasing applications of multiplex assays in companion diagnostics
    • 3.3.4 Rising awareness of early diagnosis
  • 3.4 Market Restraint Analysis
    • 3.4.1 The high investment cost of multiplex assays
    • 3.4.2 Stringent regulatory constraints and standards
  • 3.5 Market Opportunity Analysis
    • 3.5.1 Growing need for high-throughput and automated systems
    • 3.5.2 Increasing validation of the biomarkers in protein and molecular diagnostics
  • 3.6 Porter's Five Forces Analysis
  • 3.7 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)

Chapter 4 Multiplex Assay Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

  • 4.1 Global Multiplex Assay Market: Product Movement Analysis
  • 4.2 Consumables
    • 4.2.1 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.3 Instruments
    • 4.3.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.4 Software
    • 4.4.1 Software market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 Multiplex Assay Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

  • 5.1 Global Multiplex Assay Market: Type Movement Analysis
  • 5.2 Protein Multiplex Assays
    • 5.2.1 Protein multiplex assays market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.2.1.1 Planar Protein Assays
        • 5.2.1.1.1 Planar Protein Assays Market, 2018 - 2030 (USD Million)
      • 5.2.1.2 Bead-Based Protein Assays
        • 5.2.1.2.1 Bead-Based Protein Assays Market, 2018 - 2030 (USD Million)
  • 5.3 Nucleic Acid Multiplex Assays
    • 5.3.1 Nucleic Acid Multiplex Assays market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.3.1.1 Planar Nucleic Acid Assays
        • 5.3.1.1.1 Planar Nucleic Acid Assays Market, 2018 - 2030 (USD Million)
      • 5.3.1.2 Bead-Based Nucleic Acid Assays
        • 5.3.1.2.1 Bead-Based Nucleic Acid Assays Market, 2018 - 2030 (USD Million)
  • 5.4 Cell-Based Multiplex Assays
    • 5.4.1 Cell-Based Multiplex Assays market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 Multiplex Assay Market- Segment Analysis, by Technology, 2018 - 2030 (USD Million)

  • 6.1 Multiplex Assay Market: Technology Movement Analysis
  • 6.2 Flow Cytometry
    • 6.2.1 Flow Cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3 Fluorescence Detection
    • 6.3.1 Fluorescence Detection market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4 Luminescence
    • 6.4.1 Luminescence market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5 Multiplex Real-Time PCR
    • 6.5.1 Multiplex Real-Time PCR market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6 Other Technologies
    • 6.6.1 Other Technologies market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Multiplex Assay Market: - Segment Analysis, by Application, 2018 - 2030 (USD Million)

  • 7.1 Multiplex Assay Market: Application Movement Analysis
  • 7.2 Research & Development
    • 7.2.1 Research & Development market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.2.1.1 Drug Discovery & Development
        • 7.2.1.1.1 Drug Discovery & Development Market, 2018 - 2030 (USD Million)
      • 7.2.1.2 Biomarker Discovery & Validation
        • 7.2.1.2.1 Biomarker Discovery & Validation Market, 2018 - 2030 (USD Million)
  • 7.3 Clinical Diagnostics
    • 7.3.1 Clinical Diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.3.1.1 Infectious Diseases
        • 7.3.1.1.1 Infectious Diseases Market, 2018 - 2030 (USD Million)
      • 7.3.1.2 Cancer
        • 7.3.1.2.1 Cancer Market, 2018 - 2030 (USD Million)
      • 7.3.1.3 Cardiovascular Diseases
        • 7.3.1.3.1 Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
      • 7.3.1.4 Autoimmune Diseases
        • 7.3.1.4.1 Autoimmune Diseases Market, 2018 - 2030 (USD Million)
      • 7.3.1.5 Nervous System Disorders
        • 7.3.1.5.1 Nervous System Disorders Market, 2018 - 2030 (USD Million)
      • 7.3.1.6 Metabolism & Endocrinology Disorders
        • 7.3.1.6.1 Metabolism & Endocrinology Disorders Market, 2018 - 2030 (USD Million)
      • 7.3.1.7 Other Diseases
        • 7.3.1.7.1 Other Diseases Market, 2018 - 2030 (USD Million)

Chapter 8 Multiplex Assay Market: - Segment Analysis, by End User, 2018 - 2030 (USD Million)

  • 8.1 Multiplex Assay Market: End User Movement Analysis
  • 8.2 Pharmaceutical & Biotechnology Companies
    • 8.2.1 Pharmaceutical & Biotechnology Companies market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.3 Hospitals & Diagnostic laboratories
    • 8.3.1 Hospitals & Diagnostic laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4 Research & Academic Institutes
    • 8.4.1 Research & Academic Institutes market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.5 Other End Users
    • 8.5.1 Other End Users market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Multiplex Assay Market: - Segment Analysis, by Region, 2018 - 2030 (USD Million)

  • 9.1 Multiplex Assay Market: Regional Movement Analysis
  • 9.2 North America
    • 9.2.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.2.2 U.S.
      • 9.2.2.1 Key Country Dynamics
      • 9.2.2.2 Competitive Scenario
      • 9.2.2.3 Prevalence Insights
      • 9.2.2.4 Regulatory Framework
      • 9.2.2.5 Reimbursement Structure
      • 9.2.2.6 U.S. Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.2.3 Canada
      • 9.2.3.1 Key Country Dynamics
      • 9.2.3.2 Competitive Scenario
      • 9.2.3.3 Prevalence Insights
      • 9.2.3.4 Regulatory Framework
      • 9.2.3.5 Reimbursement Structure
      • 9.2.3.6 Canada Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3 Mexico
      • 9.3.3.1 Key Country Dynamics
      • 9.3.3.2 Competitive Scenario
      • 9.3.3.3 Prevalence Insights
      • 9.3.3.4 Regulatory Framework
      • 9.3.3.5 Reimbursement Structure
      • 9.3.3.6 Mexico Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.3 Europe
    • 9.3.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.2 UK
      • 9.3.2.1 Key Country Dynamics
      • 9.3.2.2 Competitive Scenario
      • 9.3.2.3 Prevalence Insights
      • 9.3.2.4 Regulatory Framework
      • 9.3.2.5 Reimbursement Structure
      • 9.3.2.6 UK Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1 Key Country Dynamics
      • 9.3.3.2 Competitive Scenario
      • 9.3.3.3 Prevalence Insights
      • 9.3.3.4 Regulatory Framework
      • 9.3.3.5 Reimbursement Structure
      • 9.3.3.6 Germany Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.3.4 Spain
      • 9.3.4.1 Key Country Dynamics
      • 9.3.4.2 Competitive Scenario
      • 9.3.4.3 Prevalence Insights
      • 9.3.4.4 Regulatory Framework
      • 9.3.4.5 Reimbursement Structure
      • 9.3.4.6 Spain Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.3.5 France
      • 9.3.5.1 Key Country Dynamics
      • 9.3.5.2 Competitive Scenario
      • 9.3.5.3 Prevalence Insights
      • 9.3.5.4 Regulatory Framework
      • 9.3.5.5 Reimbursement Structure
      • 9.3.5.6 France Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.3.6 Italy
      • 9.3.6.1 Key Country Dynamics
      • 9.3.6.2 Competitive Scenario
      • 9.3.6.3 Prevalence Insights
      • 9.3.6.4 Regulatory Framework
      • 9.3.6.5 Reimbursement Structure
      • 9.3.6.6 Italy Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.3.7 Denmark
      • 9.3.7.1 Key Country Dynamics
      • 9.3.7.2 Competitive Scenario
      • 9.3.7.3 Prevalence Insights
      • 9.3.7.4 Regulatory Framework
      • 9.3.7.5 Reimbursement Structure
      • 9.3.7.6 Denmark Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.3.8 Sweden
      • 9.3.8.1 Key Country Dynamics
      • 9.3.8.2 Competitive Scenario
      • 9.3.8.3 Prevalence Insights
      • 9.3.8.4 Regulatory Framework
      • 9.3.8.5 Reimbursement Structure
      • 9.3.8.6 Sweden Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.3.9 Norway
      • 9.3.9.1 Key Country Dynamics
      • 9.3.9.2 Competitive Scenario
      • 9.3.9.3 Prevalence Insights
      • 9.3.9.4 Regulatory Framework
      • 9.3.9.5 Reimbursement Structure
      • 9.3.9.6 Norway Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4 Asia Pacific
    • 9.4.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.2 Japan
      • 9.4.2.1 Key Country Dynamics
      • 9.4.2.2 Competitive Scenario
      • 9.4.2.3 Prevalence Insights
      • 9.4.2.4 Regulatory Framework
      • 9.4.2.5 Reimbursement Structure
      • 9.4.2.6 Japan Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3 China
      • 9.4.3.1 Key Country Dynamics
      • 9.4.3.2 Competitive Scenario
      • 9.4.3.3 Prevalence Insights
      • 9.4.3.4 Regulatory Framework
      • 9.4.3.5 Reimbursement Structure
      • 9.4.3.6 China Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4 India
      • 9.4.4.1 Key Country Dynamics
      • 9.4.4.2 Competitive Scenario
      • 9.4.4.3 Prevalence Insights
      • 9.4.4.4 Regulatory Framework
      • 9.4.4.5 Reimbursement Structure
      • 9.4.4.6 India Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.4.5 South Korea
      • 9.4.5.1 Key Country Dynamics
      • 9.4.5.2 Competitive Scenario
      • 9.4.5.3 Prevalence Insights
      • 9.4.5.4 Regulatory Framework
      • 9.4.5.5 Reimbursement Structure
      • 9.4.5.6 South Korea Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.4.6 Australia
      • 9.4.6.1 Key Country Dynamics
      • 9.4.6.2 Competitive Scenario
      • 9.4.6.3 Prevalence Insights
      • 9.4.6.4 Regulatory Framework
      • 9.4.6.5 Reimbursement Structure
      • 9.4.6.6 Australia Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.4.7 Thailand
      • 9.4.7.1 Key Country Dynamics
      • 9.4.7.2 Competitive Scenario
      • 9.4.7.3 Prevalence Insights
      • 9.4.7.4 Regulatory Framework
      • 9.4.7.5 Reimbursement Structure
      • 9.4.7.6 Thailand Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5 Latin America
    • 9.5.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.2 Brazil
      • 9.5.2.1 Key Country Dynamics
      • 9.5.2.2 Competitive Scenario
      • 9.5.2.3 Prevalence Insights
      • 9.5.2.4 Regulatory Framework
      • 9.5.2.5 Reimbursement Structure
      • 9.5.2.6 Brazil Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3 Argentina
      • 9.5.3.1 Key Country Dynamics
      • 9.5.3.2 Competitive Scenario
      • 9.5.3.3 Prevalence Insights
      • 9.5.3.4 Regulatory Framework
      • 9.5.3.5 Reimbursement Structure
      • 9.5.3.6 Argentina Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6 Middle East & Africa (MEA)
    • 9.6.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.6.2 South Africa
      • 9.6.2.1 Key Country Dynamics
      • 9.6.2.2 Competitive Scenario
      • 9.6.2.3 Prevalence Insights
      • 9.6.2.4 Regulatory Framework
      • 9.6.2.5 Reimbursement Structure
      • 9.6.2.6 South Africa Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3 Saudi Arabia
      • 9.6.3.1 Key Country Dynamics
      • 9.6.3.2 Competitive Scenario
      • 9.6.3.3 Prevalence Insights
      • 9.6.3.4 Regulatory Framework
      • 9.6.3.5 Reimbursement Structure
      • 9.6.3.6 Saudi Arabia Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4 UAE
      • 9.6.4.1 Key Country Dynamics
      • 9.6.4.2 Competitive Scenario
      • 9.6.4.3 Prevalence Insights
      • 9.6.4.4 Regulatory Framework
      • 9.6.4.5 Reimbursement Structure
      • 9.6.4.6 UAE Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5 Kuwait
      • 9.6.5.1 Key Country Dynamics
      • 9.6.5.2 Competitive Scenario
      • 9.6.5.3 Prevalence Insights
      • 9.6.5.4 Regulatory Framework
      • 9.6.5.5 Reimbursement Structure
      • 9.6.5.6 Kuwait Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 10 Competitive Landscape

  • 10.1 Participant's overview
  • 10.2 Company/Competition Categorization
  • 10.3 Vendor Landscape
    • 10.3.1 BIO-RAD LABORATORIES, INC.
      • 10.3.1.1 Company overview
      • 10.3.1.2 Financial performance
      • 10.3.1.3 Services benchmarking
      • 10.3.1.4 Strategic initiatives
    • 10.3.2 ABCAM PLC.
      • 10.3.2.1 Company overview
      • 10.3.2.2 Financial performance
      • 10.3.2.3 Services benchmarking
      • 10.3.2.4 Strategic initiatives
    • 10.3.3 R&D SYSTEMS, INC.
      • 10.3.3.1 Company overview
      • 10.3.3.2 Financial performance
      • 10.3.3.3 Services benchmarking
      • 10.3.3.4 Strategic initiatives
    • 10.3.4 MERCK KGAA
      • 10.3.4.1 Company overview
      • 10.3.4.2 Financial performance
      • 10.3.4.3 Services benchmarking
      • 10.3.4.4 Strategic initiatives
    • 10.3.5 ASSAY GENIE.
      • 10.3.5.1 Company overview
      • 10.3.5.2 Financial performance
      • 10.3.5.3 Services benchmarking
      • 10.3.5.4 Strategic initiatives
    • 10.3.6 PROMEGA CONNECTIONS
      • 10.3.6.1 Company overview
      • 10.3.6.2 Financial performance
      • 10.3.6.3 Services benchmarking
      • 10.3.6.4 Strategic initiatives
    • 10.3.7 QIAGEN N.V.
      • 10.3.7.1 Company overview
      • 10.3.7.2 Financial performance
      • 10.3.7.3 Services benchmarking
      • 10.3.7.4 Strategic initiatives
    • 10.3.8 THERMO FISHER SCIENTIFIC, INC.
      • 10.3.8.1 Company overview
      • 10.3.8.2 Financial performance
      • 10.3.8.3 Services benchmarking
      • 10.3.8.4 Strategic initiatives
    • 10.3.9 LUMINEX CORPORATION
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Services benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10 PERKIN ELMER INC.
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Services benchmarking
      • 10.3.10.4. Strategic initiatives
    • 10.3.11 ADVANCED CELL DIAGNOSTICS, INC.
      • 10.3.11.1 Company overview
      • 10.3.11.2 Financial performance
      • 10.3.11.3 Services benchmarking
      • 10.3.11.4 Strategic initiatives
    • 10.1.12 SEEGENE INC.
      • 10.3.12.1 Company overview
      • 10.3.12.2 Financial performance
      • 10.3.12.3 Services benchmarking
      • 10.3.12.4 Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 Global Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 5 Global Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 6 Global Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 7 Global Multiplex Assay Market, by End User, 2018 - 2030 (USD Million)
  • Table 8 Global Multiplex Assay Market, by Region, 2018 - 2030 (USD Million)
  • Table 9 North America Multiplex Assay Market, by Country, 2018 - 2030 (USD Million)
  • Table 10 North America Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 11 North America Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 12 North America Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 13 North America Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 14 North America Multiplex Assay Market, by End User, 2018 - 2030 (USD Million)
  • Table 15 U.S. Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 16 U.S. Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 17 U.S. Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 18 U.S. Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 19 U.S. Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 20 Canada Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 21 Canada Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 22 Canada Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 23 Canada Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 Canada Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 25 Mexico Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 26 Mexico Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 Mexico Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 28 Mexico Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 29 Mexico Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 30 Europe Multiplex Assay Market, by Country, 2018 - 2030 (USD Million)
  • Table 31 Europe Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 Europe Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 33 Europe Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 34 Europe Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 35 Europe Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 36 Germany Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 37 Germany Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 38 Germany Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 39 Germany Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 Germany Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 41 UK Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 42 UK Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 43 UK Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 44 UK Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 45 UK Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 46 France Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 47 France Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 48 France Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 49 France Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 50 France Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 51 Italy Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 52 Italy Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 53 Italy Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 54 Italy Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 55 Italy Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 56 Spain Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 57 Spain Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 58 Spain Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 59 Spain Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 60 Spain Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 61 Denmark Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 62 Denmark Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 63 Denmark Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 64 Denmark Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 Denmark Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 66 Sweden Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 67 Sweden Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 68 Sweden Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 69 Sweden Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 70 Sweden Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 71 Norway Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 72 Norway Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 73 Norway Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 74 Norway Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 75 Norway Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific Multiplex Assay Market, by Country, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 82 China Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 83 China Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 84 China Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 85 China Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 86 China Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 87 Japan Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 88 Japan Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 89 Japan Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 90 Japan Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 91 Japan Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 92 India Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 93 India Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 94 India Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 95 India Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 96 India Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 97 South Korea Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 98 South Korea Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 99 South Korea Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 100 South Korea Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 101 South Korea Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 102 Australia Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 103 Australia Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 104 Australia Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 105 Australia Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 106 Australia Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 107 Thailand Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 108 Thailand Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 109 Thailand Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 110 Thailand Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 111 Thailand Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 112 Latin America Multiplex Assay Market, by Country, 2018 - 2030 (USD Million)
  • Table 113 Latin America Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 114 Latin America Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 115 Latin America Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 116 Latin America Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 117 Latin America Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 118 Brazil Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 119 Brazil Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 120 Brazil Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 121 Brazil Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 122 Brazil Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 123 Argentina Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 124 Argentina Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 125 Argentina Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 126 Argentina Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 127 Argentina Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa Multiplex Assay Market, by Country, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 134 South Africa Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 135 South Africa Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 136 South Africa Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 137 South Africa Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 138 South Africa Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 144 UAE Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 145 UAE Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 146 UAE Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 147 UAE Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 148 UAE Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
  • Table 149 Kuwait Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
  • Table 150 Kuwait Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
  • Table 151 Kuwait Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
  • Table 152 Kuwait Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
  • Table 153 Kuwait Multiplex Assay Market, End User, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Multiplex Assays Market Segmentation
  • Fig. 8 Market Snapshot, 2021
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2021
  • Fig. 16 Global Multiplex Assay Market: Products Movement Analysis
  • Fig. 17 Global Multiplex Assay Market, for Consumables, 2018 - 2030 (USD Million)
  • Fig. 18 Global Multiplex Assay Market, for Instruments, 2018 - 2030 (USD Million)
  • Fig. 19 Global Multiplex Assay Market, for Software, 2018 - 2030 (USD Million)
  • Fig. 20 Global Multiplex Assay Market: Type Movement Analysis
  • Fig. 21 Global Multiplex Assay Market, for Protein Multiplex Assays, 2018 - 2030 (USD Million)
  • Fig. 22 Global Multiplex Assay Market, for Planar Protein Assays, 2018 - 2030 (USD Million)
  • Fig. 23 Global Multiplex Assay Market, for Bead-Based Protein Assays, 2018 - 2030 (USD Million)
  • Fig. 24 Global Multiplex Assay Market, for Nucleic Acid Multiplex Assays, 2018 - 2030 (USD Million)
  • Fig. 25 Global Multiplex Assay Market, for Planar Nucleic Acid Assays, 2018 - 2030 (USD Million)
  • Fig. 26 Global Multiplex Assay Market, for Bead-Based Nucleic Acid Assays, 2018 - 2030 (USD Million)
  • Fig. 27 Global Multiplex Assay Market, for Cell-Based Multiplex Assays, 2018 - 2030 (USD Million)
  • Fig. 28 Global Multiplex Assay Market: Technology Movement Analysis
  • Fig. 29 Global Multiplex Assay Market, for Flow Cytometry, 2018 - 2030 (USD Million)
  • Fig. 30 Global Multiplex Assay Market, for Fluorescence Detection, 2018 - 2030 (USD Million)
  • Fig. 31 Global Multiplex Assay Market, for Luminescence,2018 - 2030 (USD Million)
  • Fig. 32 Global Multiplex Assay Market, for Multiplex Real-Time PCR, 2018 - 2030 (USD Million)
  • Fig. 33 Global Multiplex Assay Market, for Other Technologies, 2018 - 2030 (USD Million)
  • Fig. 34 Global Multiplex Assay Market: Application Movement Analysis
  • Fig. 35 Global Multiplex Assay Market, for Research & Development, 2018 - 2030 (USD Million)
  • Fig. 36 Global Multiplex Assay Market, for Drug Discovery & Development, 2018 - 2030 (USD Million)
  • Fig. 37 Global Multiplex Assay Market, for Biomarker Discovery & Validation, 2018 - 2030 (USD Million)
  • Fig. 38 Global Multiplex Assay Market, for Clinical Diagnostics, 2018 - 2030 (USD Million)
  • Fig. 39 Global Multiplex Assay Market, for Infectious Diseases, 2018 - 2030 (USD Million)
  • Fig. 40 Global Multiplex Assay Market, for Cancer, 2018 - 2030 (USD Million)
  • Fig. 41 Global Multiplex Assay Market, for Cardiovascular Diseases, 2018 - 2030 (USD Million)
  • Fig. 42 Global Multiplex Assay Market, for Autoimmune Diseases, 2018 - 2030 (USD Million)
  • Fig. 43 Global Multiplex Assay Market, for Nervous System Disorders, 2018 - 2030 (USD Million)
  • Fig. 44 Global Multiplex Assay Market, for Metabolism & Endocrinology Disorders, 2018 - 2030 (USD Million)
  • Fig. 45 Global Multiplex Assay Market, for Other Diseases, 2018 - 2030 (USD Million)
  • Fig. 46 Global Multiplex Assay Market: End User Movement Analysis
  • Fig. 47 Global Multiplex Assay Market, for Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
  • Fig. 48 Global Multiplex Assay Market, for Hospitals & Diagnostic Laboratories, 2018 - 2030 (USD Million)
  • Fig. 49 Global Multiplex Assay Market, for Research & Academic Institutes, 2018 - 2030 (USD Million)
  • Fig. 50 Global Multiplex Assay Market, for Other End Users, 2018 - 2030 (USD Million)
  • Fig. 51 Regional Marketplace: Key Takeaways
  • Fig. 52 Regional Outlook, 2024 & 2030
  • Fig. 53 Global Multiplex Assay Market: Regional Movement Analysis
  • Fig. 54 North America Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 55 U.S. Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 56 Canada Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 57 Mexico Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 58 Europe Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 59 Germany Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 60 UK Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 61 France Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 62 Italy Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 63 Spain Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 64 Denmark Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 65 Sweden Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 66 Norway Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 67 Asia Pacific Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 68 Japan Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 69 China Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 70 India Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 71 South Korea Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 72 Australia Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 73 Thailand Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 74 Latin America Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 75 Brazil Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 76 Argentina Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 77 Middle East and Africa Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 78 South Africa Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 79 Saudi Arabia Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 80 UAE Multiplex Assay Market, 2018 - 2030 (USD Million)
  • Fig. 81 Kuwait Multiplex Assay Market, 2018 - 2030 (USD Million)